"Rokotetutkimuskeskus on Tampereen yliopiston lääketieteen ja terveysteknologian tiedekunnan alaisuudessa toimiva erikoisyksikkö. Toteutamme tieteellisesti ja eettisesti korkeatasoisia, kliinisiä rokotetutkimuksia yhdessä rokotevalmistajien kanssa, sekä omia akateemisia tutkimushankkeita. Tavoitteemme on saada käyttöön uusia, entistä turvallisempia ja tehokkaampia rokotteita lapsille, nuorille ja aikuisille. Rokotetutkimuskeskusta johtaa professori Mika Rämet."

During the past decade, Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)" are "Pneumococcal Infections" (2 trials). Many other conditions were trialed in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)" in a lesser frequency.

Most popular intervention types in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Prevnar 13®" (1 trials), "Prevnar 13™" (1 trials), "V114" (1 trials), "V114 Lot 1" (1 trials) and "V114 Lot 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".